PPAR-δ Activation Ameliorates Diabetes-Induced Cognitive Dysfunction by Modulating Integrin-linked Kinase and AMPA Receptor Function

References

• Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol. 1997;145(4):301–308. doi: 10.1093/oxfordjournals.aje.a009106.
   PubMed Web of Science ®Google Scholar
• Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes. 2004;53(2):474–481.
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64–74. doi: 10.1016/S1474-4422(05)70284-2.
   PubMed Web of Science ®Google Scholar
• Kulstad JJ, Green PS, Cook DG, Watson GS, Reger MA, Baker LD, Plymate SR, Asthana S, Rhoads K, Mehta PD, Craft S. Differential modulation of plasma b-amyloid by insulin in patients with Alzheimer disease. Neurology. 2006;66(10):1506–1510. doi: 10.1212/01.wnl.0000216274.58185.09.
   PubMed Web of Science ®Google Scholar
• Zhao W-Q, Townsend M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer’s disease. Biochim Biophys Acta - Mol Basis Dis. 2009;1792(5):482–496. doi: 10.1016/j.bbadis.2008.10.014.
   Web of Science ®Google Scholar
• Park SA. A common pathogenic mechanism linking type-2 diabetes and Alzheimer’s disease: evidence from animal models. J Clin Neurol. 2011;7(1):10–18. doi: 10.3988/jcn.2011.7.1.10.
   PubMed Web of Science ®Google Scholar
• Bloemer J, Bhattacharya S, Amin R, Suppiramaniam V. Impaired insulin signaling and mechanisms of memory loss. Prog Mol Biol Transl Sci. 2014;121:413–449. doi: 10.1016/B978-0-12-800101-1.00013-2.
   PubMed Web of Science ®Google Scholar
• Stolk RP, Breteler MM, Ott A, Pols HA, Lamberts SW, Grobbee DE, Hofman A. Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care. 1997;20(5):792. doi: 10.2337/diacare.20.5.792.
   PubMed Web of Science ®Google Scholar
• Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999;53(9):1937–1942. doi: 10.1212/WNL.53.9.1937.
   PubMed Web of Science ®Google Scholar
• Petot GJ, Traore F, Debanne SM, Lerner AJ, Smyth KA, Friedland RP. Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life. Metabolism. 2003;52(3):279–281. doi: 10.1053/meta.2003.50066.
   PubMed Web of Science ®Google Scholar
• Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D. Cerebrospinal fluid and plasma insulin levels in Alzheimer’s disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology. 1998;50(1):164–168. doi: 10.1212/WNL.50.1.164.
   PubMed Web of Science ®Google Scholar
• Messier C. Diabetes, Alzheimer’s disease and apolipoprotein genotype. Exp Gerontol. 2003;38(9):941–946. doi: 10.1016/S0531-5565(03)00153-0.
   PubMed Web of Science ®Google Scholar
• Cole GM, Frautschy SA. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer’s Disease. Exp Gerontol. 2007;42(1-2):10–21. doi: 10.1016/j.exger.2006.08.009.
   PubMed Web of Science ®Google Scholar
• Rajput MS, Sarkar PD. Modulation of neuro-inflammatory condition, acetylcholinesterase and antioxidant levels by genistein attenuates diabetes associated cognitive decline in mice. Chem Biol Interact. 2017;268:93–102. doi: 10.1016/j.cbi.2017.02.021.
   PubMed Web of Science ®Google Scholar
• Pedersen W, Flynn E. Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer’s disease. Neurobiol Dis. 2004;17(3):500–506. doi: 10.1016/j.nbd.2004.08.003.
   PubMed Web of Science ®Google Scholar
• Woods SC, Seeley RJ, Baskin DG, Schwartz MW. Insulin and the blood-brain barrier. Curr Pharm Des. 2003;9(10):795–800.
   PubMed Web of Science ®Google Scholar
• Neumann KF, Rojo L, Navarrete LP, Farías G, Reyes P, Maccioni RB. Insulin resistance and Alzheimer’s disease: molecular links & clinical implications. Curr Alzheimer Res. 2008;5:438–447.
   PubMed Web of Science ®Google Scholar
• Gray SM, Meijer RI, Barrett EJ. Insulin regulates brain function, but how does it get there? Diabetes. 2014;63(12):3992–3997. doi: 10.2337/db14-0340.
   PubMed Web of Science ®Google Scholar
• Heni M, Hennige AM, Peter A, Siegel-Axel D, Ordelheide A-M, Krebs N, Machicao F, Fritsche A, Häring H-U, Staiger H. Insulin Promotes Glycogen Storage and Cell Proliferation in Primary Human Astrocytes. PLoS One. 2011;6(6):e21594. doi: 10.1371/journal.pone.0021594.
   PubMed Web of Science ®Google Scholar
• Kimura K, Tanida M, Nagata N, Inaba Y, Watanabe H, Nagashimada M, Ota T, Asahara S, Kido Y, Matsumoto M, et al. Central insulin action activates Kupffer cells by suppressing hepatic vagal activation via the nicotinic alpha 7 acetylcholine receptor, Cell. Rep. 2016;14:2362–2374. doi: 10.1016/j.celrep.2016.02.032.
   Google Scholar
• Alessi DR, Cohen P. Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev. 1998;8(1):55–62.
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J. 2000;346 Pt 3:561–576.
   PubMedGoogle Scholar
• Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378(6559):785–789. doi: 10.1038/378785a0.
   PubMed Web of Science ®Google Scholar
• Hooper C, Markevich V, Plattner F, Killick R, Schofield E, Engel T, Hernandez F, Anderton B, Rosenblum K, Bliss T, et al. Glycogen synthase kinase-3 inhibition is integral to long-term potentiation. Eur J Neurosci. 2007;25(1):81–86. doi: 10.1111/j.1460-9568.2006.05245.x.
   PubMed Web of Science ®Google Scholar
• Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T, et al. LTP inhibits LTD in the hippocampus via regulation of GSK3β. Neuron. 2007;53(5):703–717. doi: 10.1016/j.neuron.2007.01.029.
   PubMed Web of Science ®Google Scholar
• Zhu L-Q, Wang S-H, Liu D, Yin Y-Y, Tian Q, Wang X-C, Wang Q, Chen J-G, Wang J-Z. Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments. J Neurosci. 2007;27(45):12211–12220. doi: 10.1523/JNEUROSCI.3321-07.2007.
   PubMed Web of Science ®Google Scholar
• Seung TW, Park SK, Kang JY, Kim JM, Park SH, Kwon BS, Lee CJ, Kang JE, Kim DO, Lee U, Heo HJ. Ethyl acetate fraction from Hibiscus sabdariffa L. attenuates diabetes-associated cognitive impairment in mice. Food Res Int. 2018;105:589–598. doi: 10.1016/j.foodres.2017.11.063.
   PubMed Web of Science ®Google Scholar
• Mazzotti A, Caletti MT, Marchignoli F, Forlani G, Marchesini G. Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? Dig Liver Dis. 2017;49(3):235–240. doi: 10.1016/j.dld.2016.12.028.
   PubMedGoogle Scholar
• Kennedy G, Hardman RJ, Macpherson H, Scholey AB, Pipingas A. How does exercise reduce the rate of age-associated cognitive decline? A review of potential mechanisms. J Alzheimers Dis. 2016;55(1):1–18. doi: 10.3233/JAD-160665.
   Web of Science ®Google Scholar
• Chen Q, Mo R, Wu N, Zou X, Shi C, Gong J, Li J, Fang K, Wang D, Yang D, et al. Berberine ameliorates diabetes-associated cognitive decline through modulation of aberrant inflammation response and insulin signaling pathway in DM rats. Front Pharmacol. 2017;8:334. doi: 10.3389/fphar.2017.00334.
   PubMed Web of Science ®Google Scholar
• Ma S, Zhong D, Ma P, Li G, Hua W, Sun Y, Liu N, Zhang L, Zhang W. Exogenous hydrogen sulfide ameliorates diabetes-associated cognitive decline by regulating the mitochondria-mediated apoptotic pathway and IL-23/IL-17 expression in db/db mice. Cell Physiol Biochem. 2017;41(5):1838–1850. doi: 10.1159/000471932.
   PubMed Web of Science ®Google Scholar
• de la Monte SM. Insulin resistance and neurodegeneration: progress towards the development of new therapeutics for Alzheimer’s disease. Drugs. 2017;77(1):47–65. doi: 10.1007/s40265-016-0674-0.
   PubMed Web of Science ®Google Scholar
• Li X-L, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience. 2002;113(3):607–615.
   PubMed Web of Science ®Google Scholar
• Sharma AN, Elased KM, Garrett TL, Lucot JB. Neurobehavioral deficits in db/db diabetic mice. Physiol Behav. 2010;101(3):381–388. doi: 10.1016/j.physbeh.2010.07.002.
   PubMed Web of Science ®Google Scholar
• Dinel A-L, André C, Aubert A, Ferreira G, Layé S, Castanon N. Cognitive and emotional alterations are related to hippocampalinflammation in a mouse model of metabolic syndrome. PLoS One. 2011;6(9):e24325. doi: 10.1371/journal.pone.0024325.
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Kamal A, Ramakers GM, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes. 1996;45(9):1259–1266. doi: 10.2337/diab.45.9.1259.
   PubMed Web of Science ®Google Scholar
• de la Monte SM, Tong M, Lester-Coll N, Plater M, Wands JR. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer’s disease. J Alzheimers Dis. 2006;10(1):89–109.
   PubMed Web of Science ®Google Scholar
• Shonesy BC, Thiruchelvam K, Parameshwaran K, Rahman EA, Karuppagounder SS, Huggins KW, Pinkert CA, Amin R, Dhanasekaran M, Suppiramaniam V. Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents. Neurobiol Aging. 2012;33(2):430.e5–430.e18. doi: 10.1016/j.neurobiolaging.2010.12.002.
   Web of Science ®Google Scholar
• Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. Embo J. 1996;15(19):5336–5348. doi: 10.1002/j.1460-2075.1996.tb00918.x.
   PubMed Web of Science ®Google Scholar
• Blumberg B, Sabbagh W, Juguilon H, Bolado J, van Meter CM, Ong ES, Evans RM. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. 1998;12(20):3195–3205. doi: 10.1101/gad.12.20.3195.
   PubMed Web of Science ®Google Scholar
• Willson TM, Brown PJ, Sternbach DD, Henke BR. The PPARs: from orphan receptors to drug discovery. J Med Chem. 2000;43(4):527–550. doi: 10.1021/jm990554g.
   PubMed Web of Science ®Google Scholar
• Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science. 2001;294(5548):1866–1870. doi: 10.1126/science.294.5548.1866.
   PubMed Web of Science ®Google Scholar
• Robinson E, Grieve DJ. Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease. Pharmacol Ther. 2009;122(3):246–263. doi: 10.1016/j.pharmthera.2009.03.003.
   PubMed Web of Science ®Google Scholar
• van Bilsen M, van Nieuwenhoven FA. PPARs as therapeutic targets in cardiovascular disease. Expert Opin Ther Targets. 2010;14(10):1029–1045. doi: 10.1517/14728222.2010.512917.
   PubMed Web of Science ®Google Scholar
• Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR. Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol. 2006;199(2):265–273. doi: 10.1016/j.expneurol.2006.01.018.
   PubMed Web of Science ®Google Scholar
• Chalimoniuk M, King-Pospisil K, Pedersen WA, Malecki A, Wylegala E, Mattson MP, Hennig B, Toborek M. Arachidonic acid increases choline acetyltransferase activity in spinal cord neurons through a protein kinase C-mediated mechanism. J Neurochem. 2004;90(3):629–636. doi: 10.1111/j.1471-4159.2004.02535.x.
   PubMed Web of Science ®Google Scholar
• Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry. 2005;13:950–958. doi: 10.1176/appi.ajgp.13.11.950.
   PubMed Web of Science ®Google Scholar
• Risner ME, Saunders AM, Altman JFB, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA, Roses AD; Rosiglitazone in Alzheimer’s Disease Study Group. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s disease. Pharmacogenomics J. 2006;6(4):246–254. doi: 10.1038/sj.tpj.6500369.
   PubMed Web of Science ®Google Scholar
• Kariharan T, Nanayakkara G, Parameshwaran K, Bagasrawala I, Ahuja M, Abdel-Rahman E, Amin AT, Dhanasekaran M, Suppiramaniam V, Amin RH. Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression. Neurobiol Aging. 2015;36(3):1451–1461. doi: 10.1016/j.neurobiolaging.2014.09.028.
   PubMed Web of Science ®Google Scholar
• Kalinin S, Richardson JC, Feinstein DL. A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer’s disease. Curr Alzheimer Res. 2009;6(5):431–437. doi: 10.2174/156720509789207949.
   PubMed Web of Science ®Google Scholar
• Braissant O, Wahli W. Differential expression of peroxisome proliferator-activated receptor-α, -β, and -γ during rat embryonic development. Endocrinology. 1998;139(6):2748–2754. doi: 10.1210/endo.139.6.6049.
   PubMed Web of Science ®Google Scholar
• Woods JW, Tanen M, Figueroa DJ, Biswas C, Zycband E, Moller DE, Austin CP, Berger JP. Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons. Brain Res. 2003;975(1-2):10–21. doi: 10.1016/S0006-8993(03)02515-0.
   PubMed Web of Science ®Google Scholar
• Di-Poï N, Tan NS, Michalik L, Wahli W, Desvergne B. Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell. 2002;10(4):721–733.
   PubMed Web of Science ®Google Scholar
• Bhattacharya D, Dunaway EP, Bhattacharya S, Bloemer J, Buabeid M, Escobar M, Suppiramaniam V, Dhanasekaran M. Impaired ILK function is associated with deficits in hippocampal based memory and synaptic plasticity in a FASD rat model. PLoS One. 2015;10(8):e0135700. doi: 10.1371/journal.pone.0135700.
   PubMed Web of Science ®Google Scholar
• Yu X, Shen N, Zhang M-L, Pan F-Y, Wang C, Jia W-P, Liu C, Gao Q, Gao X, Xue B, Li C-J. Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice. Embo J. 2011;30(18):3754–3765. doi: 10.1038/emboj.2011.277.
   PubMed Web of Science ®Google Scholar
• Zeng X, Xie XH, Tietz EI. Reduction of GABA-mediated inhibitory postsynaptic potentials in hippocampal CA1 pyramidal neurons following oral flurazepam administration. Neuroscience. 1995;66(1):87–99. doi: 10.1016/0306-4522(94)00558-M.
   PubMed Web of Science ®Google Scholar
• Zeng XJ, Tietz EI. Benzodiazepine tolerance at GABAergic synapses on hippocampal CA1 pyramidal cells. Synapse. 1999;31(4):263–277. doi: 10.1002/(SICI)1098-2396(19990315)31:4 < 263::AID-SYN4 > 3.0.CO;2-J.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Kimble W, Buabeid M, Bhattacharya D, Bloemer J, Alhowail A, Reed M, Dhanasekaran M, Escobar M, Suppiramaniam V. Altered AMPA receptor expression plays an important role in inducing bidirectional synaptic plasticity during contextual fear memory reconsolidation. Neurobiol Learn Mem. 2017;139:98–108. doi: 10.1016/j.nlm.2016.12.013.
   PubMed Web of Science ®Google Scholar
• Parameshwaran K, Buabeid MA, Bhattacharya S, Uthayathas S, Kariharan T, Dhanasekaran M, Suppiramaniam V. Long term alterations in synaptic physiology, expression of β2 nicotinic receptors and ERK1/2 signaling in the hippocampus of rats with prenatal nicotine exposure. Neurobiol Learn Mem. 2013;106:102–111. doi: 10.1016/j.nlm.2013.07.007.
   PubMed Web of Science ®Google Scholar
• Anderson WW, Collingridge GL. Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J Neurosci Methods. 2007;162(1-2):346–356. doi: 10.1016/j.jneumeth.2006.12.018.
   PubMed Web of Science ®Google Scholar
• Oomura Y, Aou S, Fukunaga K. Prandial increase of leptin in the brain activates spatial learning and memory. Pathophysiology. 2010;17(2):119–127. doi: 10.1016/j.pathophys.2009.04.004.
   PubMedGoogle Scholar
• Zhao Q, Matsumoto K, Tsuneyama K, Tanaka K, Li F, Shibahara N, Miyata T, Yokozawa T. Diabetes-induced central cholinergic neuronal loss and cognitive deficit are attenuated by tacrine and a Chinese herbal prescription, kangen-karyu: elucidation in type 2 diabetes db/db mice. J Pharmacol Sci. 2011;117(4):230–242. doi: 10.1254/jphs.11115FP.
   PubMed Web of Science ®Google Scholar
• Malenka RC. Synaptic plasticity in the hippocampus: LTP and LTD. Cell. 1994;78(4):535–538.
   PubMed Web of Science ®Google Scholar
• Lunch MA. Long-term potentiation and memory. Physiol Rev. 2004;84:87–136. doi: 10.1152/physrev.00014.2003.
   PubMed Web of Science ®Google Scholar
• Citri A, Malenka RC. Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacol. 2008;33(1):18–41. doi: 10.1038/sj.npp.1301559.
   PubMed Web of Science ®Google Scholar
• Izumi Y, Yamada KA, Matsukawa M, Zorumski CF. Effects of insulin on long-term potentiation in hippocampal slices from diabetic rats. Diabetologia. 2003;46(7):1007–1012. doi: 10.1007/s00125-003-1144-2.
   PubMed Web of Science ®Google Scholar
• Swanger SA, Chen W, Wells G, Burger PB, Tankovic A, Bhattacharya S, Strong KL, Hu C, Kusumoto H, Zhang J, Adams DR. Mechanistic insight into NMDA receptor dysregulation by rare variants in the GluN2A and GluN2B agonist binding domains. Am J Hum Genet. 2016;99(6):1261–1280. doi: 10.1016/j.ajhg.2016.10.002.
   PubMed Web of Science ®Google Scholar
• Ogden KK, Chen W, Swanger SA, McDaniel MJ, Fan LZ, Hu C, Tankovic A, Kusumoto H, Kosobucki GJ, Schulien AJ, Su Z. Molecular mechanism of disease-associated mutations in the pre-M1 helix of NMDA receptors and potential rescue pharmacology. PLoS Genet. 2017;13(1):e1006536. doi: 10.1371/journal.pgen.1006536.
   PubMed Web of Science ®Google Scholar
• Kaiser TM, Kell SA, Kusumoto H, Shaulsky G, Bhattacharya S, Epplin MP, Strong KL, Miller EJ, Cox BD, Menaldino DS, Liotta DC. The bioactive protein-ligand conformation of GluN2C-selective positive allosteric modulators bound to the NMDA receptor. Mol Pharmacol. 2018;93(2):141–156. doi: 10.1124/mol.117.110940.
   PubMedGoogle Scholar
• Bhattacharya S, Khatri A, Swanger SA, DiRaddo JO, Yi F, Hansen KB, Yuan H, Traynelis SF. Triheteromeric GluN1/GluN2A/GluN2C NMDARs with unique single-channel properties are the dominant receptor population in cerebellar granule cells. Neuron. 2018;99(2):315–328. doi: 10.1016/j.neuron.2018.06.010.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Ma Y, Dunn AR, Bradner JM, Scimemi A, Miller GW, Traynelis SF, Wichmann T. NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate. J Neurosci Res. 2018;96(7):1324–1335. doi: 10.1002/jnr.24230.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Traynelis SF. Unique biology and single-channel properties of GluN2A-and GluN2C-containing Triheteromeric N-Methyl-D-Aspartate receptors. J Exp Neurosci. 2018;12. doi: 10.1177/1179069518810423.
   Web of Science ®Google Scholar